Hi folks, its my 1st post here. Felt a bit positive after reading some of the long time mets survivors.
I was diagnosed with triple positive (high 90%) in 2020, stage 2. Did the full paclitaxel+herceptin and RT cycle. Have been on tamoxifen for last 5 years. In Jan this year started feeling bone pain and MRI showed fracture and doctor's asked for PET SCAN and it showed an active uptick on S1. Repeated MRI with contrast and showed multiple lesions but PET seemed to indicate only one active area. Did a biopsy..which was not too succesful, resulted in only 5% of the sample having tumor cells and within that ER was at 40% (stain intensity of only +2). Both PR and Her2 negative. So from a very strong triple positive have gone to low ER+. Oncologist was going to start me on letrozole/Kisqali...but another PET SCAN done a week before showed multiple uptick at newer location within spine and now rib. Now oncologist wants to put me on capecitabine. His reasoning is that in the last 3 months it spread to newer bone location and given that I am low ER this time, he wants this route. There is also the ongoing debate on whether the low ER could have been an artifact of the low volume tumor available from the biopsy. Wish me luck. Thanks for listening.